Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rotrosen

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
The American Journal of Psychiatry|June 6, 2018
Where's Our Lin Zexu? A Call for Leadership and Resources to Address the Opioid EpidemicJohn Rotrosen
Handbook of Experimental Pharmacology|January 1, 2020
Clinical Trials for Opioid Use DisorderEsther Blessing, Sanya Virani, John Rotrosen
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2017
Steven H FerrisJohn Rotrosen, Raymond T Bartus, Samuel Gershon
Journal of Urban Health : Bulletin of the New York Academy of Medicine|August 29, 2014
Effects of regulation on methadone and buprenorphine provision in the wake of Hurricane SandyBridget McClure, Sonia Mendoza, Laura Duncan, et al.
Postgraduate Medicine|October 13, 2009
Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facilityLenard A Adler, Frank Guida, Shirley Irons, et al.
Journal of Substance Abuse Treatment|November 9, 2020
Patients' perspectives on initiating treatment with extended-release naltrexone (XR-NTX)Phoebe Gauthier, Peter Greco, Sarah Meyers-Ohki, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|March 13, 2014
Psychiatric comorbidity, red flag behaviors, and associated outcomes among office-based buprenorphine patients following Hurricane SandyArthur R Williams, Babak Tofighi, John Rotrosen, et al.
The Journal of Clinical Psychiatry|April 22, 2022
Co-occurring Depression and Suicidal Ideation in Opioid Use Disorder: Prevalence and Response During Treatment With Buprenorphine-Naloxone and Injection NaltrexonePeter J Na, Jennifer Scodes, Marc Fishman, et al.
Addiction (Abingdon, England)|September 12, 2015
Validation of an audio computer-assisted self-interview (ACASI) version of the alcohol, smoking and substance involvement screening test (ASSIST) in primary care patientsJennifer McNeely, Shiela M Strauss, John Rotrosen, et al.
Lancet (London, England)|July 22, 2023
Misclassification of overdose events in the X:BOT study - Authors' replyJoshua D Lee, Edward V Nunes, Paul Van Veldhuisen, et al.
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
The American Journal of Psychiatry|June 6, 2018
Where's Our Lin Zexu? A Call for Leadership and Resources to Address the Opioid EpidemicJohn Rotrosen
Handbook of Experimental Pharmacology|January 1, 2020
Clinical Trials for Opioid Use DisorderEsther Blessing, Sanya Virani, John Rotrosen
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2017
Steven H FerrisJohn Rotrosen, Raymond T Bartus, Samuel Gershon
Journal of Urban Health : Bulletin of the New York Academy of Medicine|August 29, 2014
Effects of regulation on methadone and buprenorphine provision in the wake of Hurricane SandyBridget McClure, Sonia Mendoza, Laura Duncan, et al.
Postgraduate Medicine|October 13, 2009
Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facilityLenard A Adler, Frank Guida, Shirley Irons, et al.
Journal of Substance Abuse Treatment|November 9, 2020
Patients' perspectives on initiating treatment with extended-release naltrexone (XR-NTX)Phoebe Gauthier, Peter Greco, Sarah Meyers-Ohki, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|March 13, 2014
Psychiatric comorbidity, red flag behaviors, and associated outcomes among office-based buprenorphine patients following Hurricane SandyArthur R Williams, Babak Tofighi, John Rotrosen, et al.
The Journal of Clinical Psychiatry|April 22, 2022
Co-occurring Depression and Suicidal Ideation in Opioid Use Disorder: Prevalence and Response During Treatment With Buprenorphine-Naloxone and Injection NaltrexonePeter J Na, Jennifer Scodes, Marc Fishman, et al.
Addiction (Abingdon, England)|September 12, 2015
Validation of an audio computer-assisted self-interview (ACASI) version of the alcohol, smoking and substance involvement screening test (ASSIST) in primary care patientsJennifer McNeely, Shiela M Strauss, John Rotrosen, et al.
Lancet (London, England)|July 22, 2023
Misclassification of overdose events in the X:BOT study - Authors' replyJoshua D Lee, Edward V Nunes, Paul Van Veldhuisen, et al.
Pageof 16